Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant-Reference-Cited by-同舟云学术

Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant

Published:2021 Issue:34 Volume:3 Page:728-730
ISSN:2096-7071
Container-title:China CDC Weekly
language:en
Short-container-title:

Author:

Wang Fuzhen, ,An Zhijie,Rodewald Lance,Wu Dan,Tang Lin,Zheng Hui,Liu Qianqian,F. Gao George,Yin Zundong

Publisher

Chinese Center for Disease Control and Prevention

Subject

Applied Mathematics,General Mathematics

Link

http://weekly.chinacdc.cn/en/article/pdf/preview/10.46234/ccdcw2021.179

Reference6 articles.

1. Kang M, Yi Y, Li Y, Sun LM, Deng AP, Hu T, et al. Effectiveness of inactivated COVID-19 vaccines against COVID-19 pneumonia and severe illness caused by the B.1.617.2 (Delta) variant: evidence from an outbreak in Guangdong, China. http://dx.doi.org/10.2139/ssrn.3895639. [2021-8-5].

2. World Health Organization. Tracking SARS-CoV-2 variants. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. [2021-8-12].

3. Liu FF, Zheng CJ, Wang LP, Geng MJ, Chen H, Zhou S, et al. Interpretation of the protocol for prevention and control of COVID-19 in China (Edition 8). China CDC Wkly 2021;3(25):527 − 30. http://dx.doi.org/10.46234/ccdcw2021.138.

4. Share of the population fully vaccinated against COVID-19. OurWorldInData.org. https://ourworldindata.org/grapher/share-people-fully-vaccinated-covid. [2021-8-12].

5. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395(10223):470 − 3. http://dx.doi.org/10.1016/S0140-6736(20)30185-9.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study;BMJ Open;2022-07

2. Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study;Emerging Microbes & Infections;2022-02-16

3. SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines;The Lancet Infectious Diseases;2021-11

4. Science-based COVID-19 vaccine development;National Science Review;2021-10

5. Epidemiology Features and Effectiveness of Vaccination and Non-Pharmaceutical Interventions of Delta and Lambda SARS-CoV-2 Variants;China CDC Weekly;2021